Associated Press
FILE - In this Jan. 20, 2010 file photo, Andrew Witty, CEO of GlaxoSmithKline, speaks in New York. GlaxoSmithKline LLC will pay $3 billion and plead guilty to promoting two popular drugs for unapproved uses and to failing to disclose important safety information on a third in the largest health care fraud settlement in U.S. history, the Justice Department said Monday. (AP Photo/Mark Lennihan, File)

View gallery

500 photos

National news events

View Comments (1)